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Caspases are the main executioners of apoptosis as well as
interleukin (IL)-1b and IL-18 conversion to active forms. They
are activated after acute kidney injuries. In this study, we
evaluated the importance of the caspase family in the
pathogenesis and recovery of glycerol-induced acute renal
failure in rats (Gly-ARF). Rats were treated with pan-caspase
or selective caspase 1 and 3 inhibitors at the moment we
injected glycerol. Renal function, renal histology (HE),
transferase-mediated deoxynucleotidyl transferase
deoxyuridine triphosphate nick end labeling staining for
apoptosis, leukocytes infiltration (immunohistochemistry),
renal expression of IL-1b and IL-18 (immunohistochemistry
and Western blot), tubular regeneration (5-bromo-20-
deoxyuridine (BrdU) incorporation), and P27Kip expression
(Western blot) were evaluated at appropriate times. All
inhibitors reduced the renal function impairment.
Pan-caspase and caspase-3 inhibitors reduced cellular death
(necrosis and apoptosis) 24 h after Gly-ARF. All caspases
inhibitors reduced macrophages infiltration. The expression
of total IL-1b was enhanced in Gly-ARF, but the active IL-1b
and IL-18 forms were abolished in pan-caspase treated rats.
Caspase-1 inhibitor attenuated Gly-ARF but not tubular injury
suggesting glomerular hemodynamic improvement. There
was striking regenerative response 48 h after Gly-ARF
characterized by enhanced BrdU incorporation and reduced
expression of p27Kip. This response was not blunted by
caspases inhibition. Our findings demonstrate that caspases
participate in important pathogenic mechanisms in Gly-ARF
such as inflammation, apoptosis, vasoconstriction, and
tubular necrosis. The early inhibition of caspases attenuates
these mechanisms and reduces the renal function
impairment in Gly-ARF.
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Caspases are a family of cysteine-proteases that are activated
during renal injury and are implicated in the pathogenesis of
acute renal failure (ARF).1–4 Caspase 9 is activated after
mitochondrial release of proapoptotic molecules in response
to intrinsic signals such as hypoxia, reactive species,
ceramide, and growth factor deprivation.5 On the other
hand, caspase 8 is activated after interaction of tumor
necrosis factor alpha (TNF-a) and FAS ligand with cellular
membrane death receptors. Both pathways activate effectors
caspases 3, 6, and 7 that target several cytosolic and nuclear
substrates executing the process of apoptosis.5 Other
members of caspase family such as caspases 1, 4, and 5 are
not primarily involved in apoptosis, but convert precursors
of the inflammatory cytokines interleukin (IL)-1b and IL-18
to active forms6,7 and may be relevant in the recruitment and
infiltration of leukocytes in the renal parenchyma after renal
injury.1,8,9 Furthermore, there is evidence that caspases exert
important functions beyond apoptosis and inflammation,
including the control of cell cycle progression.10
Glycerol-induced ARF (Gly-ARF) in rodents is mediated
by renal ischemia and myoglobin nephrotoxicity.11,12 The
release of catalytic iron13,14 or the redox cycle of the
myoglobin heme15 induces an oxidative stress and lipid
peroxidation of the proximal tubular cell resulting in tubular
necrosis in the cortical area. The role of apoptosis and
inflammation has not been evaluated yet in the pathogenesis
of Gly-ARF. As reactive species can trigger apoptosis through
the mitochondrial pathway16 and inflammation through
activation of the transcription factor nuclear factor-kB,17 it is
possible that these mechanisms are relevant in this model.
The aim of this study is to evaluate the importance of the
caspases in cell injury, inflammation and tubular regenera-
tion in Gly-ARF. The role of caspases will be addressed
through the administration of caspase inhibitors.
RESULTS
General caspases inhibition
Renal function. Renal function was analyzed 24 h after
induction of Gly-ARF. Gly-ARF rats treated with the pan-
caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-flu-oro-
methylketone (Z-VAD-FMK) showed evident renal function
protection. Both serum creatinine and urea were comparable
to the levels observed in controls and were significantly lower
than untreated Gly-ARF rats (Table 1). A more accurate
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evaluation through creatinine clearance showed that the
protection was partial, since the creatinine clearance of
Z-VAD -FMK treated rats was significantly higher than
untreated rats, but lower than the observed in controls.
Tubular cell death. The histological examination of the
kidneys by optical microscopy showed severe cortical acute
tubular necrosis (ATN) in Gly-ARF. The broad pattern of
tubular necrosis in this model allowed a quantitative analysis
of totally necrotic and denuded tubules per high-power field
(HPF  400). This objective analysis showed that the
Z-VAD-FMK treatment significantly reduced the prevalence
of ATN at 24 h (Figure 1).
As the role of apoptotic cell death had not been described
yet in this model, we initially looked for transferase-mediated
deoxynucleotidyl transferase deoxyuridine triphosphate nick
end labeling (TUNEL) positive cells at different moments
after induction of Gly-ARF. We observed a significant
increase in TUNEL positive tubular cells at 6 h in the
medullar zone. In later evaluations at 12 and 24 h, the
amount of TUNEL positive cells in renal medulla did not
differ from control (Figure 2a). In the renal cortex, there were
few TUNEL positive cells that were unchanged by Gly-ARF
(control: 0.1570.05, Gly-ARF 6 h: 0.370.16, Gly-ARF 12 h:
0.1470.05, and Gly-ARF 24 h: 0.1070.05, NS). The treat-
ment with Z-VAD-FMK reduced the expression of medullar
TUNEL positive cells to a level similar to control group
(Figure 2b).
Inflammation. The sequential analysis of leukocytes
accumulated in the kidney tissue is depicted in Table 2. We
observed a significant and progressive increase in the number
of macrophages (anti-equine dermal-1 positive cells) present
in the renal interstitium, mainly in the outer medulla, during
the period of observation (6–120 h). The Z-VAD-FMK
treatment reduced the macrophage infiltration at 24 h.
T lymphocytes (anti-MSA10P positive cells) were frequent
in controls as well as in Gly-ARF rats, mainly in cortex and
outer medulla interstitium. The differences observed during
the course of Gly-ARF and after Z-VAD-FMK treatment were
not significant.
The kidney tissue expression of IL-1b and IL-18 was
evaluated by immunohistochemistry. IL-1b was expressed in
tubule cells predominantly in the renal cortex, whereas IL-18
was found expressed in tubule cell both in cortex and outer
medulla (Figure 3). The computer assisted semiquantitative
analysis (Table 3) showed that Gly-ARF had increased
expression of IL-1b and unchanged expression of IL-18.
The Z-VAD-FMK administration had no influence in these
interleukins immunostaining. However, the antibodies
recognize both the precursor (35 kDa for IL-1b and 24 kDa
for IL-18) and the mature form (17 kDa for IL-1b and 18 kDa
for IL-18), and to evaluate the active form expression we
performed Western blotting for both cytokines (Figure 4).
The Western blotting showed that IL-1b and IL-18 active
forms were expressed in Gly-ARF, but were absent in
Gly-ARF treated with Z-VAD-FMK.
Cell cycle. The tubular cell proliferation evaluated by
5-bromo-20-deoxyuridineb (BrdU) incorporation was intense
both in the renal cortex and renal medulla 48 h after
Gly-ARF. The Z-VAD-FMK administration to Gly-ARF rats
had no significant influence on tubular cell proliferation
(Figure 5).
The expression of the protein p27kip, a negative regulator
of cell cycle, was clearly detected in the renal cortex of control
Table 1 | Renal function evaluation 24 h after Gly-ARF when Z-VAD-FMK was administered concomitant to glycerol 5 ml/kg
Control
n : 11
Control+Z-VAD-FMK
n : 3
Gly-ARF
n : 3
Gly-ARF+Control+Z-VAD-FMK
n : 4
Urea (mg/dl) 3.772 153.4a 6175
Creatinine (mg/dl) 0.3970.02 0.5670.03 1.7170.28a 0.5770.07
Cr. clearance (ml/min/100 g) 429725 100719a 270774b
Gly-ARF showed marked deterioration of the renal function that was partly preserved with Z-VAD-FMK. Gly-ARF: glycerol-induced acute renal failure. Z-VAD-FMK: pan-caspase
inhibitor. Cr. clearance: creatinine clearance.
aPo0.01 vs other groups.
bPo0.01 vs control.
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Figure 1 | Evaluation of acute tubular necrosis (ATN) in Gly-ARF
5 ml/kg at 24 h. The pan-caspase inhibitor (Z-VAD-FMK) treated rats
had less ATN than untreated rats. *Po0.05 vs Gly-ARF.
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Figure 2 | Evaluation of tubular cell apoptosis (TUNEL positive
cells) in Gly-ARF 5 ml/kg. (a) Number of TUNEL positive cells
significantly increased in the renal medulla 6 h after Gly-ARF
induction. N: 5 rats/group. (b) Separate experiment showing that
Z-VAD-FMK significantly reduced the number of TUNEL positive cells
6 h after Gly-ARF 5 ml/kg. N: 5 rats/group. *Po0.05 vs other groups.
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rats (Western blot) and disappeared in Gly-ARF. The
administration of Z-VAD-FMK did not restore the protein
p27kip expression (Figure 6).
Selective caspases inhibition
The selectivity of peptide-based inhibitors used in this study
had already been determined in vitro using specific substrates
and recombinant human caspases 1–10.18 The only potent
inhibitor of effector caspases (3 and 7) was Ac-DEVD-CHO,
whereas caspases 1, 4, and 5 were inactivated preferentially by
Ac-YVAD-CHO and also partially by Ac-DEVD-CHO. As
effector caspases are not inhibited by Ac-YVAD-CHO, the
‘selective’ inhibitors may discriminate the preferential role of
apoptotic or inflammatory caspases in the pathogenic
process. To ease the comprehension of the text, the selective
inhibitors will be referred as caspase-1 (Ac-YVAD-CHO) and
caspase-3 inhibitors (Ac-DEVD-CHO).
Table 2 | Leukocytes detected in renal parenchyma after Gly-ARF 5 ml/kg
Gly-ARF
Gly-ARF+Z-VAD-FMK
Control 6 h 24 h 72 h 120 h 24 h
ED-1+cells (macrophages)
Cortex 7.871.3 16.271.8 38.977.5 49.075.9 108.0715.0 8.472.7a
Medulla 5.570.9 19.374.5 100.8722.6 101.2724.1 227.2730.0 9.372.2a
MS010P+ cells (T lymphocytes)
Cortex 32.579.2 21.072.3 33.473.5 19.173.7 — 20.577.3b
Medulla 12.675.7 15.674.2 26.175.7 19.473.0 — 12.376.7b
The number of positive anti-ED1 cells (macrophages) increased progressively after Gly-ARF both in cortical and medullar interstitium, and the Z-VAD-FMK administration
significantly reduced this increase at 24 h. The anti-MS010P positive cells (T lymphocytes) did not show significant variations after Gly-ARF.
Gly-ARF: glycerol-induced acute renal failure; Z-VAD-FMK: pan-caspase inhibitor administered concomitant to glycerol; ED, equine dermal.
aPo0.001 vs Gly-ARF 24 h.
bNS vs Gly-ARF at 24 h. N: 4–7 rats/group.
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Figure 3 | Evaluation of immunohistochemistry for IL-1b and
IL-18 in the renal parenchyma. IL-1b immunostaining observed at
low power field ( 40) in (a) control rat and (b) Gly-ARF. IL-1b
expression predominates in the renal cortex and is enhanced
in Gly-ARF. At higher magnification ( 400), IL-1b expression in
(c) control rat and (d) Gly-ARF showing tubule cells positivity. The
expression of IL-18 in (e) control rat and (f) Gly-ARF were similar and
observed in the cortex and outer medulla tubule cells.
Table 3 | IL-1b and IL-18 immunostaining score 24 h after
Gly-ARF 5 ml/kg
Control Gly-ARE
Gly-ARF+
Z-VAD-FMK
IL-1b positive gridfields (%) 19.278.7 66.975.5a 77.075.3a
IL-18 positive gridfields (%) 52.176.5 51.276.3 56.475.6
Digital images acquired by video microscopy using KS 300 Imaging System, Zeiss
were marked with gridlines 10 10. Numbers represent percentage of stained
gridfields analyzed in 15 cortical (IL-1b) and 10 cortical plus 10 outer medullar (IL-18)
 400 HPF/rat.
Gly-ARF, glycerol-induced acute renal failure; Z-VAD-FMK: pan-caspase inhibitor
administered concomitant to glycerol; IL-1b, interleukin-1b.
aPo0.01 vs control. N: 4–7 rats/group.
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Figure 4 | Western blot from cortical kidney homogenates
showing the expression of IL-1b and IL-18. (a) The IL-1b inactive
35 kDa precursor was detected in controls (C), Gly-ARF (Gly), and Gly-
ARF treated with Z-VAD-FMK (Glyþ Z-VAD-FMK), whereas the 17 kDa
active IL-1b form was detected in Gly-ARF and absent in Gly-ARFþ
Z-VAD-FMK. (b) The IL-18 inactive 24 kDa precursor was detected in
controls (C), Gly-ARF (Gly), and Gly-ARF treated with Z-VAD-FMK
(Glyþ Z-VAD-FMK), whereas the 18 kDa active IL-18 form was
detected in control and Gly-ARF and absent in Gly-ARFþ Z-VAD-FMK.
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Data regarding selective caspase inhibition are depicted in
Table 4. The higher dose of glycerol (7 ml/kg) used in this
experiment resulted in a more severe renal impairment and
tubular injury, mainly tubular apoptosis at 24 h. All caspases
inhibitors attenuated the renal function impairment evalu-
ated by serum urea and creatinine. The tubular injury
(cortical necrosis and medullar apoptosis) was reduced in
groups treated with pan-caspase and caspase-3 inhibitors,
whereas caspase-1 inhibitor failed to reduce tubular injury.
The macrophage infiltration was attenuated by all treatments.
General caspases inhibition in the course of Gly-ARF
The administration of Z-VAD-FMK 12 h after the induction
of Gly-ARF (5 ml/kg) failed to protect the renal function or
injury (Table 5). Gly-ARF rats treated with Z-VAD-FMK or
untreated showed significant and similar reduction in the
creatinine clearance at 48 h and similar degree of ATN.
DISCUSSION
Gly-ARF rats showed intense cortical ATN and significant
increase in the number of apoptotic tubular cells in the outer
medulla. TUNEL positive cells appeared very early and
peaked 6 h after Gly-ARF. The administration of pan-caspase
or selective caspases inhibitors concomitant to glycerol
attenuated the Gly-ARF in all groups. Delayed treatment
(12 h) was no longer able to protect the kidneys. Caspases 3
and 7 are the main effectors of apoptosis and pan-caspase
and caspase-3 inhibitors significantly reduced the develop-
ment of apoptosis in our experiments. Pan-caspase and
caspase-3 inhibitors also reduced the development of ATN.
Although the role of caspases is not clear in the necrosis
process, it was not surprising that caspase inhibitors
treatment attenuated ATN, since this finding had already
been described in previous studies in experimental ARF,9,19–21
and in one study using proximal tubules in vitro.2 In our
study, it was noteworthy the reduction in tubular necrosis in
rats treated with caspase-3 inhibitor. Caspase-3 can cleave
adherent junctions proteins and dismantle cell–cell contact22
as well increase calpain activity and cleavage of cell–matrix
adhesion molecules.23,24 These data suggest that caspase-3
may reduce proximal tubular cell adhesion causing cell
detachment and desquamation that may contribute to ATN
histological picture in Gly-ARF.
Caspase-1 inhibition attenuated Gly-ARF despite un-
changed tubular injury. This finding suggests that caspase-1
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Figure 5 | Number of BrdU positive cells in renal parenchyma 48 h
after Gly-ARF. There was a significant increase in BrdU positive cell
(mitosis) in Gly-ARF. Z-VAD-FMK treated rats showed positivity similar
to untreated Gly-ARF. N: 6 rats/group, *Po0.001 vs control.
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Figure 6 | Western blot from cortical kidney homogenates
showing expression of p27Kip detected in controls (c) and
absent in Gly-ARF (Gly) or Gly-ARF treated with Z-VAD-FMK
(GlyþZ-VAD-FMK).
Table 4 | Renal function, tubular injury and macrophage infiltration 24 h after Gly-ARF when pan-caspase or selective caspases
inhibitors were administered concomitant to glycerol 7 ml/kg
Control Gly-ARF Gly-ARF+Z-VAD-FMK Gly-ARF+Ac-DEVD-CHO Gly-ARF+Ac-YVAD-CHO
Urea (mg/dl) 3373 192723a 129723b 114723b 131723b
Creatinine (mg/dl) 0.4170.22 2.5070.51a 1.7870.50b 1.2470.43b 1.6270.56b
NTA (HPF) — 22.470.7 14.471.1c 11.071.7c,d 16.972.7
TUNEL+tubular cells (HPF) 0.770.2 13.571.5b 5.571.6c,d 8.371.9d 18.474.1b
ED-1+cells (HPF) 10.072.2 89.8713.7a 61.875.4b 34.678.4b 37.873.5
Gly-ARF, glycerol-induced acute renal failure; Z-VAD-FMK, pan-caspase inhibitor; Ac-DEVD-CHO, caspase-3 and 7 inhibitor; Ac-YVAD-CHO, caspase-1 inhibitor; NTA, cortical
necrotic tubules; TUNEL, transferase-mediated deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling; HPF, high-power field. TUNEL+cells (apoptosis):
mean of 15 medullar HPF fields/rat. ED-1+cells (macrophages): mean of 10 cortical plus 10 outer medullary HPF/rat. See text for details.
aPo0.05 vs other groups.
bPo0.05 vs control.
cPo0.05 vs Gly-ARF.
dPo0.05 vs Ac-YVAD-CHO. N: 5–7 rats/group.
Table 5 | Renal function and tubular injury evaluation 48 h
after Gly-ARF when Z-VAD-FMK was administered 12 h after
glycerol 5 ml/kg
Control Gly-ARF
Gly-ARF+
Z-VAD-FMK
Urea (mg/dl) 4073 113732a 132720a
Creatinine (mg/dl) 0.4070.11 0.9670.06a 0.9870.07a
Cr. clearance (ml/min/100 g) 327717 134716a 11579a
NTA (HPF) — 16.872.5 14.673.2
Administration of Z-VAD-FMK 12 h after glycerol injection failed to preserve renal
function or reduce tubular necrosis. Gly-ARF: glycerol-induced acute renal failure; Z-
VAD-FMK: pan-caspase inhibitor; Cr. clearance: creatinine clearance; NTA: cortical
necrotic tubules/HPF.
aPo0.01 vs control, N: 5 rats/group.
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inhibition has a favorable effect on glomerular hemo-
dynamics in Gly-ARF. Increased afferent resistance and
consequent reduction in the glomerular capillary hydraulic
pressure are the main hemodynamic parameters associated
with the reduced glomerular filtration rate in established Gly-
ARF.25 The endotoxemic-ARF induced by LPS injection in
rats is also characterized by severe renal vasoconstriction.26
Wang et al.27 induced LPS-ARF in caspase-1 deficient mice
and compared with wild-type controls. Their findings were
quite similar to caspase-1 inhibition in our study, with
protection of the renal function in knockout mice that was
not associated with reduced tubular necrosis or apoptosis. In
a recent paper, Tiwari et al.28 using intravital videomicro-
scopy showed that pan-caspase inhibition improved cortical
peritubular blood flow in LPS-ARF mice. This is direct
evidence that caspases are involved in the disruption of
cortical microvascular flow in LPS-ARF. IL-1b stimulates the
biosynthesis of lipid vasoactive mediators;29,30 therefore, the
reduced conversion to active IL-1b could reduce vasocon-
striction and improve glomerular filtration in ARF.
We have previously shown that neutrophil infiltration in
the kidneys is not relevant in Gly-ARF.31 Here, we focused in
the infiltration of mononuclear leukocytes. We observed
frequent T lymphocytes in the renal cortex both in controls
and in Gly-ARF rats. There was a trend to increase medullar
T lymphocytes in untreated Gly-ARF, but this finding was
not significant. A pathogenic role for T lymphocytes is well
established in renal ischemia/reperfusion injury.32–35 On the
other hand, an increase in the number of macrophages in the
renal parenchyma, mainly in the outer medulla, was
remarkable in Gly-ARF. Injured tubules release inflammatory
cytokines and chemokynes that stimulate leukocytes recruit-
ment, adhesion to endothelial and epithelial receptors, and
infiltration in the renal tissue.1,36–39 In this study, we observed
increased tubular expression of IL-1b in Gly-ARF. The
Z-VAD-FMK treatment abolished the expression of mature
IL-1b and IL-18, and reduced the infiltration of macrophages
in the kidney, particularly in the milder form of Gly-ARF
(5 ml/kg). The role of macrophages in renal injury is
heterogeneous and dependent on predominant activating
signal.40 The proinflammatory activation state results in
release of reactive oxygen species and aggravates tubular
injury.41 There is now compelling evidence that macrophages
are also able to downregulate inflammation and promote
tissue repair.42 A pathogenic role for macrophages infiltration
in ARF has been supported by recent study in which
macrophage depletion reduced ischemia/reperfusion injury.43
The kinetics of macrophages in our study showed progressive
accumulation in the kidneys even 120 h after induction of
Gly-ARF. At this point, most of the tubular injury had been
repaired and many regenerating tubules were surrounded
by macrophages in the renal cortex. The intense prevalence
of macrophages at this stage suggests a reversion from
pro-inflammatory to a reparative state of activation.
There are evidences that caspase-3 can regulate cell cycle
progression cleaving several negative regulators of cell cycle
such as Wee1, p21Waf1, and p27Kip1.44–46 Caspase 8/ mice
exhibited impaired heart muscle development and impaired
hematopoietic colony-forming activity,47,48 and in a rat
model of polycystic kidney disease the caspase inhibition
decreased proliferation on cystic and noncystic tubules.49 As
tubular regeneration is a fundamental step on renal recovery
after ATN, we evaluated the effect of Z-VAD-FMK on tubular
cell proliferation 48 h after Gly-ARF. At this point, the BrdU
labeling showed intense proliferative activity both in the
cortex and in the outer medulla. This response was well
preserved in Z-VAD-FMK treated rats, despite the fact that
this group showed initially less cellular death. We also
evaluated the expression of p27Kip1. This protein was clearly
expressed in control rats and absent in kidney homogenates
24 h after induction of Gly-ARF. The Z-VAD-FMK treated
rats also did not express p27Kip1, demonstrating that caspases
are not involved in the regulation of p27Kip1 expression in
Gly-ARF.
In conclusion, caspases have an important role in the
pathogenesis of Gly-ARF. The caspases system inhibition
reduced tubular injury, inflammation, and preserved glomer-
ular filtration. The selective approach revealed some details of
the mechanisms of protection. Caspase 3 and 7 are responsible
for most of the caspase-dependent tubular apoptosis, but
also may participate in the process of necrosis or detachment
of proximal tubular cells. A possible favorable glomerular
hemodynamic response was observed after caspase-1 inhibi-
tion. These new possibilities expand the postulated patho-
genic mechanism considered relevant in the caspases
involvement in ARF. Finally, we have shown that the tubular
regeneration is not dependent on the activity of caspases.
MATERIALS AND METHODS
Induction of glycerol ARF and caspase inhibitors treatment
Male Wistar–Hannover rats (220–260 g) were provided by Central
Biotery from our Institution. The experiments described here were
performed in accordance with the guidelines established by the
Brazilian College for Animal Experimentation. Gly-ARF was
induced after overnight fast by single intramuscular injection of
50% glycerol divided into both lower hind limbs. Controls received
saline intramuscular injection. Rats were treated with the following
caspase inhibitors peptides (Alexis Biochemicals, San Diego, CA,
USA): general or pan-caspase inhibitor Z-Val-Ala-DL-Asp-Fluoro-
methylketone (Z-VAD-FMK), Caspase-1 inhibitor Ac-Tyr-Val-Ala-
Asp-CHO (Ac-YVAD-CHO) and Caspases 3 and 7 inhibitor
Ac-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO), or vehicle (DMSO
1%). In the first series of experiments, we evaluated the participa-
tion of the family of caspases in the pathophysiology of Gly-ARF.
With this purpose, a milder form of Gly-ARF was induced (glycerol
5 ml/kg) and the pan-caspase inhibitor (4 mg/kg i.p.) was injected
immediately after glycerol injection. In a subsequent series of
experiments, the specific role of proapoptotic and proinflammatory
caspases was evaluated. Selective and general caspase inhibitors
(4 mg/kg i.p.) were administered immediately after glycerol injection
in a more severe form of the disease (glycerol 7 ml/kg). Finally, the
effect of pan-caspase inhibitor (4 mg/kg) was analyzed when the
peptide or vehicle were administered 12 h after the induction of
Gly-ARF (5 ml/kg).
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Renal function studies
Rats were expanded with water (10% body weight) by gavage and
2 h spontaneously voided urine was collected. At the end of urine
collection, blood was drawn through cardiac puncture. Serum urea,
creatinine, and urinary creatinine were measured by automated
analyzer (Cobas-Mira, Roche, Basel, Switzerland). Creatinine
clearance was calculated and normalized to 100 g body weight.
Histological analysis
Acute tubular necrosis. Kidneys were harvest, fixed in 10%
formalin, and embedded in paraffin. Longitudinal cuts (4 mm) of the
mid portion of the kidneys were stained with hematoxilin and eosin.
The number of totally necrotic and desquamated tubules (absence of
nucleus) was quantified in 15 random cortical HPD ( 400) for
each rat.
TUNEL staining. In situ detection of DNA fragmentation
characteristic of apoptotic cells was performed using TUNEL
method. Briefly, longitudinal sections of the embedded kidneys
were dewaxed, and endogenous peroxidase was blocked in 3%
peroxide hydrogen. The tissue was incubated with Proteinase K
(Roche, Mannheim, Germany) 20 mg/ml for 15 min at room
temperature, then rinsed in transferase (terminal deoxynucleotidyl
transferase) buffer (30 mM Tris, 140 mM sodium cacodylate, 1 mM
cobalt chloride, pH 7.2), incubated with terminal deoxynucleotidyl
transferase (Amershan Biosciences, Piscataway, NJ) 1:50, and
biotinylated deuridine triphosphate (Gibco, Grand Island, NY)
1:50 in terminal deoxynucleotidyl transferase buffer for 60 min at
room temperature. Labeled nuclei were detected with Vectastain
ABC (Vector Laboratories, Burlingame, CA, USA) incubation for
30 min developed by diaminobenzidine tetrahydrochloride (Dako,
Carpinteria, CA, USA) as a substrate chromogen solution. Sections
were counterstained with hematoxylin. Positive tubular cells were
counted in 15 random HPF ( 400) in the cortex and 15 in the
medulla.
Immunohistochemistry
Assessment of cellular proliferation by BrdU labeling. BrdU
100 mg/kg (Calbiochem, La Jolla, CA, USA) was injected intraperi-
toneally 1 h before killing, and the kidneys were fixed in 10%
formalin and embedded in paraffin. Longitudinal sections of the
mid-kidney were dewaxed, rehydrated, and placed in 2 N HCl at
311C for 20 min and 0.005% trypsin in phosphate-buffered saline
(PBS) at 371C for 2 min for antigen retrieval. Slides were placed in
1% non-fat milk in PBS for 1 h to block nonspecific staining. Tissue
sections were incubated in 1:50 dilution of 1% bovine serum
albumin of monoclonal anti-BrdU antibody (Dako, Glostrup,
Denmark) for 1.5 h at room temperature. After washing in PBS, a
biotinylated secondary anti-mouse antibody (Dako, Glostrup,
Denmark) prepared 1:200 dilution in 1% bovine serum albumin
was applied for 1 h. To block endogenous peroxidase slides were
incubated in 3% H2O2 for 15 min. ABC reagent (Dako, Glostrup,
Denmark) was applied to slides for 30 min followed by diamino-
benzidine tetrahydrochloride (Dako, Carpinteria, CA, USA).
Sections were counterstained with hematoxylin. The BrdU-positive
tubular cells were scored in 12 randomly selected HPF ( 400) in
the cortex and 12 fields in the medulla.
Macrophages. Slides were dewaxed and endogenous perox-
idase blocked (3% H2O2), antigen retrieving was accomplished by
heating tissue at 931C in a microwave oven in 10 mM citrate buffer,
pH 6 for 30 min. Primary anti-equine dermal-1 antibody 1:100
(Serotec, Oxford, UK) was incubated in humid camera for 1 h at
room temperature, and biotinylated universal secondary antibody
1:400 (Novocastra, Newcatle, UK) was incubated for 30 min at room
temperature. The reaction product was detected with ABC Kit
(Dako, Glostrup, Denmark) and color developed with diamino-
benzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). Equine
dermal-1 positive cells were counted in 12 randomly selected
cortical and 12 medullar tubulointerstitial HPF ( 400).
T lymphocytes. Slides were dewaxed and endogenous perox-
idase blocked (2% H2O2), and then antigen retrieving was
accomplished heating tissue at 931C for 1 min followed by 601C
for 9 min in microwave oven in 10 mM citrate buffer, pH 6. Primary
antibody (MAS010P – Monoclonal mouse anti-rat T lymphocytes,
Accurate Medical, Wesbury, NY, USA) 1:50 was incubated with the
tissue overnight at 41C. After PBS rinsing goat anti-mouse
peroxidase conjugated secondary antibody (Novocastra, Newcastle,
UK) diluted 1:200 was incubated at room temperature for 1 h. The
color was developed with diaminobenzidine tetrahydrochloride
(Dako, Carpinteria, CA, USA). MAS010P positive cells were counted
in 12 randomly selected cortical and 12 medullar tubulointerstitial
HPF ( 400).
IL-1b. Slides were dewaxed and endogenous peroxidase was
blocked in 3% H2O2 for 45 min. Antigenic retrieval in 10 mM citrate
buffer pH 6 in microwave oven 901 for 30 min followed by PBS
washing and blockage with normal goat serum for 30 min. Primary
antibody to IL-1b (rabbit anti-rat, Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA) 1:100 was incubated in humid chamber at
room temperature for 1 h followed by secondary biotinylated
antibody (goat anti-rabbit, Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA) 1:400 for 30 min. The reaction product was
detected with ABC Kit (Dako, Glostrup, Denmark) and color
developed with diaminobenzidine tetrahydrochloride (Dako,
Carpinteria, CA, USA). Fifteen random cortical HPF  400 were
captured by computerized video microscopy. Using the software KS
300 Imaging System, Zeiss, the HPF was grid lined 10 10 and the
number of stained grid fields were counted in each HPF  400. The
results are expressed as the percentage of positive grid fields.
IL-18. Slides were dewaxed and sections were washed three
times for 5 min each in permeabilization solution, which consisted
of PBS with 0.1% saponin, 0.1% bovine serum albumin, and 1%
fetal calf serum. Endogenous peroxidase was blocked in 130 ml of
permeabilization solution with 12 ml of 30% H2O2 for 30 min and
then treated with avidin and biotin blocking kit (Vector Labora-
tories, Burlingame, CA, USA) for 15 min. Goat anti-rat IL-18
antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA)
diluted 1:100 in permeabilization solution was added, and
incubation was performed overnight at 41C. Nonspecific binding
sites were blocked with rabbit serum (Dako, Glostrup, Denmark)
diluted 1:10 in permeabilization solution. Secondary antibody
(rabbit anti-goat, Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA) 1:100 dilution was added for 1 h. The reaction product was
detected with ABC Kit (Dako, Glostrup, Denmark) and color
developed with diaminobenzidine tetrahydrochloride (Dako,
Carpinteria, CA, USA). In total, 10 cortical and 10 outer medullary
HPF  400 were captured by computerized video microscopy and
the same scoring method as for IL-1b was used.
Western immunoblot analyses
Kidney cortex fragments were homogenized at 41C in 2% SDS,
60 mM Tris-HCl, and 40 ml/ml cocktail protease inhibitors (Com-
plete Mini, Roche, Mannheinn, Germany). The homogenized
solution was centrifuged at 11 000 g at 41C for 10 min. A sample
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of the supernatant was used for protein quantification using
Bradford method (Bio-Rad Laboratories, Hercules, CA, USA).
For IL-1b and IL-18 Western blotting, 50 mg of total protein in
5% glycerol, 0.03% bromophenol blue, and 10 mM dithiothreitol
were loaded in 15% SDS-polyacrylamide gel and eletrophoresed in
Laemmli solution. Molecular weight marker (Rainbow, Bio-Rad
Laboratories, Hercules, CA, USA) was used as standard. Proteins
were transferred onto nitrocellulose membranes in transfer buffer
(50 mM Tris-HCl, pH 7, 380 mM glycine, 0.1% SDS, and 20%
methanol). Nonspecific binding was blocked by incubating the
membranes overnight at 41C in 3% bovine serum albumin in
Tris-buffered saline with 0.1% Tween buffer. Primary rabbit anti-rat
IL-1b antibody 1:1000 and goat anti-rat IL-18 1:200 (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) were incubated with the
membrane for 1 h at room temperature. After washing with
Tris-buffered saline with 0.1% Tween, secondary antibody for
IL-1b (goat anti-rabbit 1:50000) and for IL-18 (donkey anti-goat
1:5000, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were
incubated for 1 h at room temperature. Immunoreactive bands
were visualized using the enhanced chemiluminescence method
(Pierce Chemical, Rockport, IL, USA).
For p27Kip1 Western blotting analysis, 60 mg of protein in 5%
glycerol, 0.03% bromophenol blue and 10 mM dithiothreitol were
loaded into 15% SDS polyacrylamide gel. Proteins were transferred
onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) in
transfer buffer (50 mM Tris-HCl, pH 7, 380 mM glycine, 0.1% SDS,
and 20% methanol). Nonspecific binding was blocked by incubating
the membranes overnight at 41C in 5% nonfat milk in PBS with
0.1% Tween-20. For the detection of p27Kip1, a mouse anti-rat
monoclonal anti-p27Kip1 antibody (Transduction Laboratories,
Lexington, KY, USA) was used at a dilution of 1:1000 and was
incubated with the membranes for 1 h at room temperature. The
blots were subsequently incubated with horseradish peroxidase-
conjugated goat anti-mouse secondary antibody 1:20 000 (New
England Biolabs, Beverly, MA, USA). Immunoreactive bands were
visualized using the enhanced chemiluminescence method (Pierce
Chemical, Rockport, IL, USA).
Statistical analysis
Data are presented as mean7s.e.m. Data were compared using
analysis of variance–Student–Newman–Keuls (biochemistry) and
Mann–Witney or Kruskal–Wallis–Dunn. P-value less than 0.05 was
considered significant.
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